Stock listing

T2 Biosystems, Inc.

Selected listing: 0A57 · LSE · USD · GB

T2 Biosystems, Inc. (LSE:0A57), Health Technology. Latest release Feb 3, 2026: T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations.

0A57:LSEUSDGBUpdated October 2, 2026
T2 Biosystems, Inc. logo
Ticker
LSE:0A57
Asset type
Stock
Sector
Health Technology
Industry
Medical Specialties
Exchange
LSE
Currency
USD

About T2 Biosystems, Inc.

T2 Biosystems, Inc. (Ticker: TTOO) is a public company based in the United States, focused on developing innovative diagnostic solutions. T2 Biosystems aims to improve patient outcomes through its advanced technology in the field of medical diagnostics.

Latest news from T2 Biosystems, Inc.

T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations

February 3, 2026

Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member

July 16, 2025

All T2 Biosystems, Inc. news →

Events

Replays

  • T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call

    Thu, Oct 10, 2024 · 04:30 PM ET

    Watch

  • T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call

    Mon, Jul 29, 2024 · 04:30 PM ET

    Watch

  • T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call

    Mon, May 06, 2024 · 04:30 PM ET

    Watch

Research T2 Biosystems, Inc.

T2 Biosystems, Inc. company profile

View the public company page for T2 Biosystems, Inc. on 6ix.

T2 Biosystems, Inc. news

Read company news and market updates connected to T2 Biosystems, Inc..

T2 Biosystems, Inc. investor events

Find investor webinars, events, and replay context for T2 Biosystems, Inc..

Alternate listings

TTOO:OTC

US · USD

Alternate listing for T2 Biosystems, Inc.; the primary context on this page is 0A57:LSE.

A3EU63:LS

DE · EUR

Alternate listing for T2 Biosystems, Inc.; the primary context on this page is 0A57:LSE.

A3EU63:LSX

DE · EUR

Alternate listing for T2 Biosystems, Inc.; the primary context on this page is 0A57:LSE.